CALT Calliditas Therapeutics
- 18.950
- -0.050-0.26%
Calliditas Therapeutics News
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
